Home Page Lawsuits Filed Lawsuit: Taxotere Hair Loss Lawsuit Filed
Taxotere Hair Loss Lawsuit Filed
Were you looking for Taxotere Permanent Hair Loss lawsuits?
Santa Clara, CA: Sanofi-Aventis is facing a defective product lawsuit alleging its cancer drug Taxotere (Docetaxel) causes hair loss. Filed by Erma Spann, the lawsuit claims Sanofi withheld important information from patients about the potential long-term side effects of Taxotere.
Spann alleges she has experienced on-going and permanent hair loss after undergoing chemotherapy involving Taxotere following a right breast partial mastectomy in February 2005.
Taxotere Hair Loss Lawsuit
Spann further alleges that Sanofi-Aventis knew or should have known that, unlike other cancer drugs, Taxotere had a high risk of permanent baldness, known as alopecia. She asserts that rather than issuing warnings regarding the potential for hair loss Sanofi concealed the information, depriving her and other patients of the opportunity to decide whether the risk of permanent baldness was justified.
Although women might accept the possibility of permanent baldness as a result of the use of Taxotere if no other product were available to treat their cancer, this was not the case, Spann states in the complaint. Before Defendants wrongful conduct resulted in thousands of women being exposed to the side effects of Taxotere, there were already similar products on the market that were at least as effective as Taxotere and did not subject female users to the same risk of disfiguring permanent alopecia as does Taxotere.
The lawsuit cites a study published in 2005, known as GEICAM 9805, that found nearly 10% of patients who took Taxotere suffered permanent hair loss. The manufacturers were aware of that study and of observations by a Denver-based oncologist in 2006, which found that more than 6% of his Taxotere patients suffered permanent hair loss.
Despite Defendants knowledge of the relevant findings from the GEICAM 9805 study, as well as reports from patients who had taken Taxotere and suffered from permanent disfiguring hair loss, Defendants failed to provide accurate information and proper warnings to physicians, healthcare providers, and patients in the United States, including Plaintiff, that patients who take Taxotere are at a significantly increased risk of suffering from permanent disfiguring hair loss, the lawsuit states. Instead, Defendants chose to withhold this information in the United States despite advising physicians, patients, and regulatory agencies in other countries, including the European Union and Canada, that Taxotere causes an increased risk of permanent disfiguring hair loss.
According to the lawsuit, Taxotere warnings continue to vaguely and misleadingly indicate that hair generally grows back after use of the drug.
Taxotere Hair Loss Legal HelpIf you or a loved one has suffered similar damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on
TAXOTERE HAIR LOSS LEGAL ARTICLES AND INTERVIEWS
Taxotere Hair Loss Lawsuits Moving Forward in MDL
New Orleans, LA: The 800 lawsuits currently enshrouded in Taxotere hair loss multidistrict litigation are moving forward by way of updated orders and directives issued February 1 by the US District Court for the Eastern District of Louisiana. Plaintiffs assert that Taxotere, a chemotherapy drug, triggered Taxotere alopecia (hair loss) that has been characterized as permanent [READ MORE]
Taxotere Docetaxel Side Effects Not Limited to Permanent Hair Loss
Washington, DC: The Taxotere hair loss lawsuit file continues to move forward, with various Pretrial Orders issued in the early part of the New Year with proposed Plaintiff and Defendant fact sheets due to be filed Monday (January 23). Meanwhile, Taxotere patients continue to deal with the frustration, disappointment and emotional turmoil that are the result of what has been for some, permanent Docetaxel hair loss [READ MORE]
Number of Consolidated Taxotere Lawsuits Jumps
New Orleans, LA: It's only been three months since the Judicial Panel on Multidistrict Litigation (JPML) consolidated the federal Taxotere lawsuits, but in that time the number of Taxotere claims added to the multidistrict litigation (MDL) has increased dramatically, a sign that women are unhappy about allegedly being put at an increased risk of side effects. Sanofi SA faces allegations it failed to adequately warn women that the hair loss they experienced as a result of the cancer treatment drug could be permanent [READ MORE]
MORE TAXOTERE HAIR LOSS LEGAL NEWS
READ MORE [ Consumer Fraud Settlements and Legal News ]
READ MORE [ Defective Products Settlements and Legal News ]
READ MORE [ Drugs/Medical Settlements and Legal News ]
ADD YOUR COMMENT ON THIS ISSUE